Treatment of fever after stroke

Conflicting evidence

Sylwia E. Wrotek, Wieslaw E. Kozak, David C Hess, Susan C. Fagan

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Approximately 50% of patients hospitalized for stroke develop fever. In fact, experimental evidence suggests that high body temperature is significantly correlated to initial stroke severity, lesion size, mortality, and neurologic outcome. Fever occurring after stroke is associated with poor outcomes. We investigated the etiology of fever after stroke and present evidence evaluating the efficacy and safety of interventions used to treat stroke-associated fever. Oral antipyretics are only marginally effective in lowering elevated body temperature in this population and may have unintended adverse consequences. Nonpharmacologic approaches to cooling have been more effective in achieving normothermia, but whether stroke outcomes can be improved remains unclear. We recommend using body temperature as a biomarker and a catalyst for aggressive investigation for an infectious etiology. Care must be taken not to exceed the new standard of a maximum acetaminophen dose of 3 g/day to avoid patient harm.

Original languageEnglish (US)
Pages (from-to)1085-1091
Number of pages7
JournalPharmacotherapy
Volume31
Issue number11
DOIs
StatePublished - Nov 1 2011

Fingerprint

Fever
Stroke
Body Temperature
Therapeutics
Patient Harm
Antipyretics
Acetaminophen
Nervous System
Biomarkers
Safety
Mortality
Population

Keywords

  • Fever
  • Hyperthermia
  • Inflammation
  • Stroke

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Treatment of fever after stroke : Conflicting evidence. / Wrotek, Sylwia E.; Kozak, Wieslaw E.; Hess, David C; Fagan, Susan C.

In: Pharmacotherapy, Vol. 31, No. 11, 01.11.2011, p. 1085-1091.

Research output: Contribution to journalReview article

Wrotek, SE, Kozak, WE, Hess, DC & Fagan, SC 2011, 'Treatment of fever after stroke: Conflicting evidence', Pharmacotherapy, vol. 31, no. 11, pp. 1085-1091. https://doi.org/10.1592/phco.31.11.1085
Wrotek, Sylwia E. ; Kozak, Wieslaw E. ; Hess, David C ; Fagan, Susan C. / Treatment of fever after stroke : Conflicting evidence. In: Pharmacotherapy. 2011 ; Vol. 31, No. 11. pp. 1085-1091.
@article{6719c178669f48eda7db4ff71ad750cd,
title = "Treatment of fever after stroke: Conflicting evidence",
abstract = "Approximately 50{\%} of patients hospitalized for stroke develop fever. In fact, experimental evidence suggests that high body temperature is significantly correlated to initial stroke severity, lesion size, mortality, and neurologic outcome. Fever occurring after stroke is associated with poor outcomes. We investigated the etiology of fever after stroke and present evidence evaluating the efficacy and safety of interventions used to treat stroke-associated fever. Oral antipyretics are only marginally effective in lowering elevated body temperature in this population and may have unintended adverse consequences. Nonpharmacologic approaches to cooling have been more effective in achieving normothermia, but whether stroke outcomes can be improved remains unclear. We recommend using body temperature as a biomarker and a catalyst for aggressive investigation for an infectious etiology. Care must be taken not to exceed the new standard of a maximum acetaminophen dose of 3 g/day to avoid patient harm.",
keywords = "Fever, Hyperthermia, Inflammation, Stroke",
author = "Wrotek, {Sylwia E.} and Kozak, {Wieslaw E.} and Hess, {David C} and Fagan, {Susan C.}",
year = "2011",
month = "11",
day = "1",
doi = "10.1592/phco.31.11.1085",
language = "English (US)",
volume = "31",
pages = "1085--1091",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "11",

}

TY - JOUR

T1 - Treatment of fever after stroke

T2 - Conflicting evidence

AU - Wrotek, Sylwia E.

AU - Kozak, Wieslaw E.

AU - Hess, David C

AU - Fagan, Susan C.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Approximately 50% of patients hospitalized for stroke develop fever. In fact, experimental evidence suggests that high body temperature is significantly correlated to initial stroke severity, lesion size, mortality, and neurologic outcome. Fever occurring after stroke is associated with poor outcomes. We investigated the etiology of fever after stroke and present evidence evaluating the efficacy and safety of interventions used to treat stroke-associated fever. Oral antipyretics are only marginally effective in lowering elevated body temperature in this population and may have unintended adverse consequences. Nonpharmacologic approaches to cooling have been more effective in achieving normothermia, but whether stroke outcomes can be improved remains unclear. We recommend using body temperature as a biomarker and a catalyst for aggressive investigation for an infectious etiology. Care must be taken not to exceed the new standard of a maximum acetaminophen dose of 3 g/day to avoid patient harm.

AB - Approximately 50% of patients hospitalized for stroke develop fever. In fact, experimental evidence suggests that high body temperature is significantly correlated to initial stroke severity, lesion size, mortality, and neurologic outcome. Fever occurring after stroke is associated with poor outcomes. We investigated the etiology of fever after stroke and present evidence evaluating the efficacy and safety of interventions used to treat stroke-associated fever. Oral antipyretics are only marginally effective in lowering elevated body temperature in this population and may have unintended adverse consequences. Nonpharmacologic approaches to cooling have been more effective in achieving normothermia, but whether stroke outcomes can be improved remains unclear. We recommend using body temperature as a biomarker and a catalyst for aggressive investigation for an infectious etiology. Care must be taken not to exceed the new standard of a maximum acetaminophen dose of 3 g/day to avoid patient harm.

KW - Fever

KW - Hyperthermia

KW - Inflammation

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=80054926460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054926460&partnerID=8YFLogxK

U2 - 10.1592/phco.31.11.1085

DO - 10.1592/phco.31.11.1085

M3 - Review article

VL - 31

SP - 1085

EP - 1091

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 11

ER -